Director, Clinical Pharmacology
Required skills
- clinical pharmacology strategy
- REM-422
- late-stage development
- regulatory submissions
- pipeline programs
- IND-enabling
- early clinical development
- dose selection
- labeling
- regulatory strategy
Nice to have
- data science
- biomolecular sciences
- chemistry
- small molecule therapies
- RNA processing
- REMaster™ technology platform
Role summary
Remix Therapeutics is seeking a Director of Clinical Pharmacology to lead the clinical pharmacology strategy for their novel small molecule therapies, focusing initially on REM-422 for oncology indications (ACC, AML/HR-MDS) and supporting pipeline programs. This role involves designing, executing, and interpreting clinical pharmacology studies from early development through registration and regulatory submissions. The successful candidate will collaborate cross-functionally with teams like Clinical Development, Regulatory Affairs, and Biostatistics, and oversee external vendors. A PhD, PharmD, or MD with 10+ years of experience in clinical pharmacology within biotech/pharma, including oncology and clinical-stage development, is required. Expertise in PK/PD, modeling, exposure-response analysis, and contributing to NDA/MAA filings is essential.
Remix Therapeutics is a clinical-stage biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and address disease drivers at their origin. Remix's REMaster™ technology platform leverages data science, biomolecular sciences and chemistry approaches to identify orally administered compounds that modulate gene expression. Remix's therapeutic approach led to the discovery of REM-422, an investigational small molecule designed to modulate RNA processing in oncology, currently being evaluated in two clinical programs, 1) the ARIA clinical study, a Phase 1/2 clinical study in adenoid cystic carcinoma (ACC), and 2) a Phase 1 clinical study in acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS).
Position Summary:
The Director of Clinical Pharmacology will play a critical role in the design, execution, analysis, and interpretation of clinical pharmacology strategies across Remix Therapeutics' development programs. The initial focus of the role will be to lead the integrated clinical pharmacology strategy for REM-422, with primary responsibility for supporting late-stage development and potential regulatory submissions. The role will also provide clinical pharmacology leadership for emerging pipeline programs to support IND-enabling and early clinical development strategies.
The successful candidate will work in a highly cross-functional environment, partnering closely with Clinical Development, Regulatory Affairs, Clinical Operations, Biostatistics, DMPK, CMC and external collaborators to drive data-driven decision making and advance clinical development.
This is an opportunity to own the clinical pharmacology strategy for REM-422 as it advances toward a potential NDA, which would be Remix's first. You will shape dose selection, labeling, and regulatory strategy for an oral RNA-targeting therapy in ACC and AML/HR-MDS, and set the clinical pharmacology approach for the pipeline programs coming behind it.
Key Responsibilities:
Qualifications:
Salary Range:
$206,000 - $252,000 USD
This range reflects the expected base salary for this position, plus bonus, equity, and benefits as applicable. Actual salaries may vary based on factors, such as skill, experience, and qualification for the role.
Similar roles
- Vice President/Senior Director, Nonclinical Drug Safety & ToxicologyRemix Therapeutics · Watertown, MA · Onsite
- Director, Commercial Project Management & Launch ExcellenceRemix Therapeutics · Watertown, MA · Onsite
- Principal Scientist, Clinical PharmacologyAbCellera · California · Onsite
- Senior Director, Clinical PharmacologyCertara · Remote · Remote
Director, Clinical Pharmacology, Modeling and SimulationAmgen · South San Francisco, CA · Onsite- Associate Director, Clinical Pharmacology & DMPKSummit Therapeutics, Inc. · Palo Alto, CA · Onsite
